Yemaneberhan H, et al.
Prevalence of wheeze and asthma in relation to atopy in urban and rural Ethiopia. Lancet 1997
1997
350:85-90

Kumar RJ
Food hypersensitivity and allergic diseaseAm J Clin Nutr
1997
66;526S-9S

Plaut M.
Newdirections in food allergy researchJ. Allergy Clin Immun
1997
94:928-30

Hatch GE.
Vitamin C in asthmaVitamin C in Health and Disease
1997
279-94

Cohen HA, et al.
Blocking effect of vitamin C in exercise-induced asthma.Arch Pediatrics Adolescense Med
1997
151:367-70

Durlach J
Magnesium depletion, magnesium deficiency, and asthma.Magnesium Res
1995
8:403-5

Melvyn R. Werbach, M.D.
Nutritional Strategies for Treating Chronic Fatigue SyndromeAlternative Medicine
2000
93-108

Grant JE, Veldee MS, Buchwald D.
Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome.J Am Diet Assoc
1996
96:383-386

Abraham GE, Flechas JD
Hypothesis: Management of fibromyalgia: rationale for the use of magnesium and malic acidJ Nutr Med
1992
3:49-59

Fukuda K., Straus SE, Hickie I, et al.
The chronic fatigue syndrome:a comprehensive approach to its definition and study.International Chronic Fatigue Syndrome Study Group. Ann Intern Med
1994
121:953-959

Jacobson W, Saich T, Borysiewicz LK, et al.
Serum folate and chronic fatigue syndrome.Neurology
1993
43:2645-2647

Anderson SA, Talbot JM
A Review of Folate Intake, Methodology and Status. Bethesda, MDFederation of American Societies for Experimental Biology
1981

Reynolds EH
Interrelationships between the neurology of folate and vitamin B12 deficiencyFolic Acid in Neurology, Psychiatry, and Internal Medicine. New York Raven Press
1979

Heseker H, Kubler W, Pudel V, Westenhoffer J.
Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiencyAnn N Y Acad Sci
1992
669:352-357

Plioplys AV, Plioplys S.
Amantadine and L-carnitine treatment of chronic fatigue syndrome.Neuropsychobiology
1997
35:16-23

Grau JM, Casademont J, Pedrol E, et al
Chronic fatigue syndrome: studies of skeletal muscle.Clin Neuropathol
1992
11:329-332

Warren G, McKendrick M, Peet M.
The role of essential fatty acids in chronic fatigue syndrome.Acta Neurol Scand
1999
99:112-116

Kuratsune H, Yamaguti K, Takahashi M, et al.
Acylcarnitine deficiency in chronic fatigue syndromeClinic Infect Dis
1994
18:S62-S67

Kuratsune H, Yamaguti K, Lindh G, et al
Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseasesInt J Mol

Kuratsune H, Yamaguti K, Lindh G, et al
Low levels of serum acylcarnitine in chronic fatigue syndrome and chronic hepatitis type C, but not seen in other diseasesInt J Mol

American Diabetes Association
Statistical Data on Diabeteshttp://www.diabetes.org

American Diabetes Association
Statistical Data on Diabeteshttp://www.diabetes.org

Harati Y
Diabetes and the Nervous SystemEndocrinol Metab Clin North America
June 1996
25

Reaven GM
Role of Insulin resistance in human diseaseBanting lecture
1988
37:1595-607

American Diabetes Association
Consensus Development Conference on Insulin ResistanceDiabetes Care
1997-1998
21:310-4

Ferri C, Bellini C, Desideri G, Valenti M, De Mattia G, Santucci A, et al
Relationship between insulin resistance and nonmodulating hypertension:linkage of metabolic abnormalities and cardiovascular riskDiabetes
1999
48:1623-30

DeFronzo RA, Ferrannini E.
Insulin resistance.Diabetes Care
1991
14:173-94

Karhapaa P, Malkki M, Laakso M.
Isolated low HDL cholesterol. An insulin-resistant stateDiabetes
1994
43:411-7

Reaven GM
Syndrome X:6 years later.J Intern Med Suppl
1994
736:13-22

Granberry MC, Fonseca VA.
Insulin resistance syndrome: options for treatment.South Med Journal
1999
92:2-15

Laakso M.
How good a marker is insulin level for insulin resistance?American Journal Epidemiol
1993
137:959-65

Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, Ehsani AA
Effects of exercise on glucose tolerance and insulin resistance.Acta Med Scand Suppl
1986
711:55-65

Mayer-Davis EJ, D'Agostino R, Karter AJ, Haffner SM, Rewers MJ, Saad M
Intensity and amount of physical activity in relation to insulin sensitivityJAMA
1998
279:669-74

Harris MI, et al
Early detection of undiagnosed diabetes mellitus:a U.S. perspectiveDiabetes Metab Res
7-8/2000
230-6

American Diabetes Association
Diabetic nephropathy(Clinical Practice Recommendations 2002)Diabetes Care, 25
2002
S85-S89

Skyler JS
Diabetic complicaitons. The importance of glucose control.Endocrinol Metab Clin North Am
1996
243-54

Ayad H
Diabetic neuropathy: classification, clinical manifestations, diagnosis and management. In:Baba S et al, eds.Diabetes Mellitus in Asia.Amsterdam:Excerpta Medica
1997
222-4

Boulton AJ, Malik RA
Diabetic neuropathyMed Clin North Am
1998
909-29

Galer BS, Gianas A, Jensen MP
Painful diabetic polyneuropathy:epidemiolgy, pain description, and quality of lifeDiabetes Res Clin Pract
February 2000
123-8

Pirart J
Diabetes mellitus and its degenerative complication: a prospective study of 4,400 patients observed between 1947 and 1973Diabetes Care
1978
1:168-188

Pirart J
Diabetes mellitus and its degenerative complication: a prospective study of 4,400 patients observed between 1947 and 1973Diabetes Care
1978
1:168-188

NIH
Consensus Conference on ImpotenceJAMA
1993
270:83-90

Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB
Impotence and its medical and psychosocial correlates:results of the Massachuesstts Male aging studyJ Urol
1994
151:54-61

Brock GB, Lue TF
Drug-induced male sexual dysfunctionDrug Saf
1993
8:414-26

Finger WW, Lund M, Slagle MA
Medications that may contribute to sexual disorders: a guide to assessment and treatment in family practiceJ Fam Pract
1997
44:33-43

Lue TF
Physiology of penile erection and pathophysiology of erectile dysfunction and priapism In: Walsh PC, Retik AB, Vaughn ED, Wein AJ, eds.Campbell's Urology. 7th ed. Philadelphia:Saunders
1998
1157-79

Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A
The international index of erectile dysfunction: a mulitdimensional scale for assesment of erectile dysfunctionUrol
1997
49:822-30

Lue TF, Broderick G.
Evaluation and nonsurgical management of erectile dysfunction and prapism In: Walsh PC, Retik AB, Vaughn ED, Wein AJ, edsCampbell's Urology 7th ed. Philadelphia: Saunders
1998
1181-1214

Lue TF, Broderick G.
Evaluation and nonsurgical management of erectile dysfunction and prapism In: Walsh PC, Retik AB, Vaughn ED, Wein AJ, edsCampbell's Urology 7th ed. Philadelphia: Saunders
1998
1181-1214

Gindin J, et al.
The effect of plant phosphatidylserine on age-assiciated memory impairment and mood in the functioning elderly.Geriatric Institue for Education and Research and Dept. of Geriatrics, Kaplan Hospital
1995

Amaducci L
Phosphatidylserine in the treatment of Alzheimer's disease: Results of a multicenter studyPsychopharmacol Bull
1988
24:130-134

Crook TH, Tinklenberg J, Yesavage J, et al.
Effects of phosphatidylserine in age-associated memory impairment.Neurology
1991
41:644-649

Crook T, Petrie W, Wells C, et al.
Effects of phosphatidylserine in Alzheimer's disease.Psychopharmacol Bull
1992
28:61-66

Palmieri G, Palmieri R, Inzoli MR, et al.
Double-blind controlled trial of phosphatidylserine in patients with senile mental deteriorationClin Trials J
1987
24:73-83

Fahey TD, Pearl M.
Hormonal effects of phosphatidylserine during 2 weeks of intense training. Abstract presented at: National Meeting of the Amercan College of Sports MedicineOrlando, Florida
1998

Villardita C, Grioli S, Salmeri G, et al.
Multicentre clinical trial of brain phosphatidylserine in elderly patients with intellectual deteriorationClin Trials J
1987
24:84-93

Fahey TD, Pearl M
The hormonal and perceptive effets of phosphatidylserine administration druing two weeks of resistive exercise-induced overtrainingBiol Sport
1998
15:243-248

Monteleone P, Beinat L, Tanzillo C, et al.
Effects of phosphatidylserine on the neuroendocrene response to physical stress in humansNeuroendocrinology
1990
52:243-248

Cenacchi T, Bertoldin T, Farina C, et al.
Cognitive decline in the elderly: a bouble-blind, placebo-controlled mulicenter study on efficacy of phosphatidylserine administration.Aging(Milano)
1993
5:123-133

Suzuki S, Yamatoya H, Sakai M, et al.
Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats.J Nutr
2001
131:2951-2956

Sakai M, Yamatoya H, Kudo S
Pharmacological effects of phosphatidylserine enzymatically synthesied from soybean lecithin on brain functions in rodents.J Nutr Sci Vitaminol (Tokyo)
1996
42:47-54

Jorisse BL, Brouns F, Van Boxtel MP, et al.
The influence of soy-derived phosphatidylserine on congnition in age-associated memory impairment.Nutr Neurosci
2001
4:121-134

Jorisse BL, Brouns F, Van Boxtel MP, et al.
The influence of soy-derived phosphatidylserine on congnition in age-associated memory impairment.Nutr Neurosci
2001
4:121-134

Reid
The roles of calcium and vitamin D in the prevention of osteoporosisEndocrinol Metab Clin North Am
1998
27:389-398

Cumming RG
Calcium intake and bone mass: a quantitative review of the evidence.Calcif Tissue Int.
1990
47:194-201

Dawson-Hughes B, Dallal GE, Krall EA, et al.
A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.N Engl J Med
1990
323:878-883

Prince RL
Diet and the prevention of osteoporotic fracturesN Engl J Med
1997
337:701-702

Homik J, Suarez-Almazor ME, Shea B, et al.
Calcium and vitamin D for corticosteroid-induced osteoporosis.Cochrane Database Syst Rev
2000
CD000952

Dawson-Hughes B, Harris SS, Krall EA, et al.
Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women.Am J Clin Nutr
2000
72:745-750

Saltman PD, Strause LG
The role of trace minerals in osteoporosis.J Am Coll Nutr
1993
12:384-389

Strause L, Saltman P, Smith KT, et al.
Spinal bone loss in postmenopausal women supplemented with calcium and trace mineralsJ Nutr
1994
124:1060-1064

Valente M, Bufalino L, Castiglione GN, et al.
effects of 1-year tereatment with ipriflavone on bone in postmenopausal women with low bone massCalcif Tissue Int
1994
54:377-380

Kovacs AB
Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosisAgents Actions
1994
41:86-87

Agnusdei D, Bufalino L, et al.
Efficacy of ipriflavone in established osteoporosis and long-term safety.Calcif Tissue Int
1997
61:S23-S27

Alexandersen P, Toussanit A, Christiansen C, et al.
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.JAMA
2001
285:1482-1488

Yamazaki I, Shino A, Shimizu Y, et al.
Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.Life Sci
1986
38:951-958

Yamazaki I, Shino A, Shimizu Y, et al.
Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.Life Sci
1986
38:951-958

Garrick MB
Prostate cancer: screening diagnosis, and management.Ann Intern Med 118
1993
118:804-18

Catalona WJ, Smith DS, Ratliff TL, et al.
Measurement of prostate-spcific antigen in serum as a screening test for prostate cancerN Engl J Med
1991
324:1156-61

Gittes RF
Carcinoma of the prostateN Engl J Med
1991
324:236-45

Rhodes L, Primka RL, Berman C, et al.
Comparison of finasteride (Proscar), a 5-alpha reductase inhibitor, and various commercial plant extracts in invitro and in vivo 5-alpha reductase inhibitionProstate
1993
22:43-51

Andro MC, Riffaud JP
Pygeum aficanum extract for the treatment of patients with benign prostatic hyperplasia: a review of 25 years of published experienceCurr Ther Res

Wilt TJ, MacDonald R, Ishani A
Beta-sitosterol for the treatment of benign porstatic hyperplasia: a systematic reviewBJU Int
1999
83:976-983

Klippel KF, Hiltl DM, Schipp B
A multicentric, placebo-controlled, double-blind clinical trial of beta-sitoserol(phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study groupBr J Urol
1997
80:427-432

Berges RR, Windeler J, Trampisch HJ, et al.
Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study GroupLancet
1995
345:1529-1532

Gerber GS, Kuznetsov D, Johnson BC, et al.
Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms.Urology
2001
58:960-964

Marks LS, Partin AW, Epstein JI, et al.
Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasiaJ Urol
2000
163:1451-1456

Wilt T, Ishani A, MacDonald R, et al.
Pygeum aficanum for benign prostatic hyperplasia.Cochrane Database Syst Rev
2002
CD001044

Preuss HG, Marcusen C, Regan J, et al.
Randomized trial of a combination of natural products (cernitin, Saw Palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).Int Urol Nephrol
2001
33:217-225

Preuss HG, Marcusen C, Regan J, et al.
Randomized trial of a combination of natural products (cernitin, Saw Palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).Int Urol Nephrol
2001
33:217-225

Brush MB, et al.
Pyridoxine in the treatment of premenstrual syndrome: a retrospective survey in 630 patients.Br J Clin Pract
1988
42:448-52

Brush MB, et al.
Pyridoxine in the treatment of premenstrual syndrome: a retrospective survey in 630 patients.Br J Clin Pract
1988
42:448-52

Sahud MA, et al.
Effect of aspirin ingestion on ascorbic acid levels in rheumatoid arthritis.Lancet
1971
1(7706):937-8

Sahud MA, et al.
Effect of aspirin ingestion on ascorbic acid levels in rheumatoid arthritis.Lancet
1971
1(7706):937-8

Delaney, G., Lee, S.F.
"Identification of Herpes Simplex Virus 1 Proteins Bound by the Novel Anti-Herpes Prunella vulgaris Polysaccharide"Dept. of Microbiology & Immunology, Dept. of Applied Oral Sciences, Dalhouse University, Halifax, Novia Scotia

Delaney, G., Lee, S.F.
"Identification of Herpes Simplex Virus 1 Proteins Bound by the Novel Anti-Herpes Prunella vulgaris Polysaccharide"Dept. of Microbiology & Immunology, Dept. of Applied Oral Sciences, Dalhouse University, Halifax, Novia Scotia

Kaartinen K, Lammi K, Hypen M, et al.
Vegan diet alleviates fibromyalgia symptomsScand J Rheumatol
2000
29:308-13

Lowe JC
The effect of cervical spinal manipulation on the sensitivity of infraspinatus trigger pointsScheduled for publication, J Myofascial Therapy
1993

Wolfe F
The clinical syndrome of fibrositis.Am. J. Medicine
1986
7-14

Griep EN, Boersma JW, Lenties EG, et al.
Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain.J Rheumatol
1998
25:1374-81

Smith JD, Terpening CM, Schmidt SOF, Gums JG
Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins.Ann Pharmacother
2001
35:702-6

Mengshail AM, Komnaes HB, Forre O.
The effects of 20 weeks of physical fitness training in female patients with fibromyalgiaClin Exp Rheumatol
1992
10:345-9

Fava M, Rosenbaum JF, MacLaughlin R, et al.
Neuroendocrine effects of S-adenosyl-L-methionine, a novel putative antidepressantJ Psychiatr Res
1990
24:177-84

Bell KM, Potkin SG, Carreon D, Plon L
S-adenosylmethionine blood levels in major depression: changes with drug treatment.Acta Neurol Scand
1994
154:15-8

Moldofsky H, Warsh JJ
Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome").Pain
1978
5:65-71

Citera G, Arias MA, Maldonado-Cocco JA, et al.
The effect of melatonin in patients with fibromyalgia: a pilot study.Clin Rheumatol
2000
19:9-13

Steinberg CL
The tocopherols (vitamin E) in the treatment of primary fibrositis.J Bone Joint Surg
1942
24:411-23

Tavoni A, Vitali C, bombardieri S, et al.
Evaluation of S-adenosylmethionine in primary fibromyalgia: A double-blind crossover study.Am J Med
1987
83:107-10

Volkmann H, Norregaard J, Jacobsen S, et al.
Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgiaScand J rheumatol
1997
26:206-11

Jacobsen S, Danneskiold-Samsoe B, Andersen RB
Oral S-adenosylmethionine in primary fibromyalgia: Double-blind clinical evaluation.Scand J Rheumatol
1991
20:294-302

Abraham G, Flechas J.
Management of fibromyalgia: Rationale for the use of magnesium and malic acid.J Nutr Med
1992
3:49-59

Russell J, Michalek J, Flechas J, et al.
Treatment of fibromyalgia syndrome with SuperMalic: A randomized, double-blind, placebo-controlled, crossover pilot study.J Rheumatol
1995
22:953-7

Kaplan KH, Goldberg DL, Galvin-Naduea M.
The impact of a meditation-based stress reduction program on fibromyalgia.Gen Hosp Psychiatry
1993
15:284-9

Blunt KL, Moez HR, Rajwani MH, Guerriero RC.
The effectiveness of chiropractic management of fibromyalgia patients: a pilot study.J Manipulative Physiol Ther
1997
20:389-99

Hains G, Hains F.
Combined ischemic compression and spinal manipulation in the treatment of fibromyalgia; a preliminary estimate of dose and efficacy.J Manipulative Physiol Ther
2000
23:225-30

Gowans SE, deHueck A, Voss S, Richardson M.
A randomized, controlled trial of exercise and education for individuals with fibromyalgia.Arthritis Care Res
1999
12:120-8

Gowans SE, deHueck A, Voss S, Richardson M.
A randomized, controlled trial of exercise and education for individuals with fibromyalgia.Arthritis Care Res
1999
12:120-8

Gowans SE, deHueck A, Voss S, Richardson M.
A randomized, controlled trial of exercise and education for individuals with fibromyalgia.Arthritis Care Res
1999
12:120-8

CDC
Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States, 1995-1999Morbidity and Mortality Weekly Report
2002
51:300-303

CDC
National Center for Health Statistics; Health, United States, 2003 With Chartbook on Trends in the Health of Americans.Hyattsville, MD: U.S. Department of Health and Human Services, CDC
2003
141

CDC
Cigarette smoking among adults-United States, 2002Morbidity and Mortality Weekly Report
2004
53:428-431

CDC
State-specific prevalence of current cigarette smoking among adults-United States 2002Morbidity and Mortality Weekly Report
2004
52:1277-1280